Brittany Dugger, PhD
Assistant Professor, Department of Neurology
Dr. Dugger completed her undergraduate studies at Michigan State University in East Lansing, Michigan, and received her PhD from the Mayo Clinic Graduate School, spending time on both the Rochester, Minnesota, and Jacksonville, Florida, campuses. Her graduate work in the laboratory of Dr. Dennis Dickson focused on the pathological heterogeneity of neurodegenerative diseases, with a main focus on dementia with Lewy bodies and rapid eye movement (REM) sleep behavior disorder. She completed a postdoctoral fellowship in the laboratory of Dr. Thomas Beach at the Banner Sun Health Research Institute in Phoenix Arizona, where she aided in a research-based human rapid autopsy program. After her postdoctoral studies, she was promoted to associate scientist; she has also served as an examining faculty member at Arizona State University, a research collaborator at Mayo Clinic in Arizona, a research associate at the University of Arizona College of Medicine, the Arizona Assistant State Director for the Parkinson’s Action Network, director of the Brains to Classrooms program, and was a member of the Arizona Parkinson’s Disease and Arizona Alzheimer’s Disease Consortiums.
Throughout the majority of her career, she has been the interface to the fields of neurology and neuropathology and has focused on clinicopathological correlates to investigate disease heterogeneity. She also expanded her portfolio to include investigations of peripheral aspects of neurodegenerative diseases. This included biochemical and immunohistochemical investigations of α-synuclein, tau, and amyloid-β in human peripheral tissues. Her work has resulted in numerous private, state, and federally funded grants and over 30 peer-reviewed manuscripts.
Dr. Dugger joined the faculty in the IND in the fall of 2015, and she provides neuropathological support for drug and biomarker discovery programs. In addition to this core support, her laboratory focuses on (1) understanding the interaction of peripheral changes to aging and neurodegenerative diseases, and (2) understanding the heterogeneity within neurodegenerative diseases.